Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
The American Journal of Physiology|June 1, 1996
Angiotensin II and contraction of isolated myocytes from human, guinea pig, and infarcted rat heartsD C Lefroy, T Crake, F Del Monte, et al.
Experimental Nephrology|May 1, 1996
Contractile dysfunction of isolated ventricular myocytes in experimental uraemiaA C McMahon, G Vescovo, L Dalla Libera, et al.
Heart (British Cardiac Society)|September 20, 2000
Apoptosis in the skeletal muscle of patients with heart failure: investigation of clinical and biochemical changesG Vescovo, M Volterrani, R Zennaro, et al.
Cardiologia (Rome, Italy)|December 31, 1997
[Myosin isoforms in skeletal muscle in patients with chronic heart decompensation: distribution and correlation with with exercise tolerance]F Serafini, G Vescovo, L Dalla Libera, et al.
International Journal of Tissue Reactions|January 1, 1986
Ventricular and aortic myosin in hypothyroid and hyperthyroid broad breasted white turkeysP Pauletto, G Scannapieco, A Angelini, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|October 1, 1986
Progression and regression of cardiac hypertrophy in hypertensive rats: biochemical and molecular changes in ventricular myosinP Pauletto, G Vescovo, G Scannapieco, et al.
Artery|January 1, 1985
Evidence of reduced atherosclerotic lesions in broad breasted white turkeys treated with oxprenololP Pauletto, A C Pessina, A Pagnan, et al.
Hypertension (Dallas, Tex. : 1979)|November 1, 1989
Ventricular myosin and creatine-kinase isoenzymes in hypertensive rats treated with captoprilP Pauletto, L Nascimben, D Piccolo, et al.
Basic Research in Cardiology|January 1, 1996
Acceleration of contraction by beta-adrenoceptor stimulation is greater in ventricular myocytes from failing than non-failing human heartsS E Harding, L A Brown, F del Monte, et al.
Minerva Cardioangiologica|July 12, 2014
(99m)Tc-DTPA scintigraphy assesses the absence of glomerular filtration rate impairment of Aliskiren in high-risk hypertensive subjects. A 12-month follow-up studyA Mazza, D Montemurro, A M Maffione, et al.
Pageof 6